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Abstract 22 
Astrocytes are proposed to converse with neurons at tripartite synapses, detecting neurotransmitter 23 
release and responding with release of gliotransmitters, which in turn modulate synaptic strength 24 
and neuronal excitability. However, a paucity of evidence from behavioral studies calls into question 25 
the importance of gliotransmission for the operation of the nervous system in healthy animals. 26 
Central pattern generator (CPG) networks in the spinal cord and brainstem coordinate the activation 27 
of muscles during stereotyped activities such as locomotion, inspiration and mastication, and may 28 
therefore provide tractable models in which to assess the contribution of gliotransmission to 29 
behaviorally relevant neural activity. Here, we review evidence for gliotransmission within spinal 30 
locomotor networks, including studies indicating that adenosine derived from astrocytes regulates 31 
the speed of locomotor activity via metamodulation of dopamine signaling. 32 
Introduction 33 
Locomotor behaviors such as walking, flying and swimming permit mammals to interact with their 34 
environment, thereby satisfying basic requirements of survival. In vertebrates, locomotion arises 35 
from the biomechanical properties of the skeletomuscular system and activity within dedicated 36 
neural circuitry in the central nervous system (CNS) (Orlovsky et al. 1999; Dickinson 2000; Grillner 37 
2006; Kiehn 2006, 2016). Whereas the planning, initiation and maintenance of movements involve 38 
various brain regions, including the cortex, basal ganglia, midbrain and hindbrain (Orlovsky et al. 39 
1999; Takakusaki et al. 2004), executive control over the timing and coordination of muscle activity 40 
is invested in networks of interneurons in the ventral horn of the spinal cord. These networks, like 41 
others in the spinal cord and brainstem that produce a stereotyped motor output, are referred to as 42 
central pattern generators (CPGs).  43 
Spinal motor networks, including the motoneurons that provide their final common output, are 44 
subject to extensive neuromodulation by substances such as the biogenic amines 5-45 
hydroxytryptamine (5-HT/serotonin), dopamine (DA) and noradrenaline, and amino acids including 46 
γ-aminobutyric acid (GABA) and glutamate (Miles and Sillar 2011). A given neuromodulator may act 47 
at multiple receptor subtypes and in a cell-type specific fashion. In addition, the effects of an 48 
individual neuromodulator may be modified by a second-order neuromodulator, a process termed 49 
metamodulation (Katz 1999; Miles and Sillar 2011). The resulting multiplicity of signaling 50 
mechanisms extends the repertoire of motor patterns that can be generated by a finite population 51 
of cells, contributing to the behavioral plasticity necessary for an animal to successfully negotiate its 52 
environment. 53 
Although in many cases neuromodulators derive from neurons, they may also be secreted by 54 
astrocytes (Araque et al. 1999, 2014), as well as from other glial cells (Jackson et al. 2017). Evidence 55 
gathered over the past two decades indicates that astrocytes release neuromodulators in response 56 
to activity in neighboring neurons, acting as the third partner, along with pre- and postsynaptic 57 
neurons, at tripartite synapses throughout the nervous system. So-called gliotransmission 58 
represents a form of information processing that extends the canonical role of astrocytes as cellular 59 
housekeepers, responsible for tasks including ion homeostasis, metabolic support and 60 
neurotransmitter clearance (Verkhratsky and Butt 2013). However, the importance of 61 
gliotransmission to the operation of the nervous system in healthy animals remains controversial, in 62 
part because of a paucity of evidence that it contributes to the production of behavior (Hamilton and 63 
Attwell 2010; Agulhon et al. 2012; Nedergaard and Verkhratsky 2012; Sloan and Barres 2014; 64 
Bazargani and Attwell 2016). 65 
Because the activity of neurons within the spinal cord determines quantifiable behaviors, spinal cord 66 
preparations may provide a tractable model for the study of gliotransmission and its role in the 67 
operation of neural networks. The lumbar spinal locomotor CPG controls the rhythmic activation of 68 
hindlimb muscles during walking and running, and rhythmic, behaviorally relevant patterns of 69 
activity can be generated by isolated CPG networks in the absence of descending and peripheral 70 
inputs. This has permitted the study of diverse neuromodulatory systems and their roles in networks 71 
controlling defined behaviors (Marder and Bucher 2001; Dickinson 2006; Whelan 2010; Harris-72 
Warrick 2011; Miles and Sillar 2011). Here, we review recent studies indicating that astrocytes within 73 
the spinal cord are a source of neuromodulatory adenosine. We then discuss the modulation of 74 
motor networks by adenosine, including recent evidence that it functions principally as a 75 
metamodulator of dopamine during motor behaviors. For the most part, we discuss evidence from 76 
mice and rats, the models used in nearly all studies of gliotransmission to date. However, a recent 77 
report implicates bidirectional signaling between neurons and glia in the regulation of behavior in 78 
Drosophila, suggesting the possibility that a greater range of organisms may be investigated in future 79 
(Ma et al. 2016). 80 
Spinal locomotor networks and neuromodulation 81 
Networks of premotor interneurons selectively excite and inhibit pools of motoneurons with precise 82 
timing to ensure appropriate contraction and relaxation within antagonistic pairs of muscles, 83 
resulting in smooth, controlled movement (Orlovsky, Deliagina and Grillner, 1999). During rhythmic 84 
locomotor behaviors, such as walking, flying and swimming, spinal networks activate muscles in a 85 
cyclically repeated sequence. Like other CPGs within the brainstem and spinal cord, including the 86 
networks that coordinate muscle contractions during chewing, swallowing and respiration (Jean 87 
2001; Marder and Bucher 2001; Feldman and Del Negro 2006; Lund and Kolta 2006), locomotor 88 
networks remain capable of generating a basic motor pattern when inputs from descending and 89 
peripheral pathways are removed (Brown 1911; Guertin 2009). 90 
The effects of neuromodulators have been studied extensively within spinal cord preparations, most 91 
notably from lampreys, Xenopus tadpoles, cats, rats and mice (Katz and Frost 1996; Katz 1999; 92 
Dickinson 2006; Harris-Warrick 2011; Miles and Sillar 2011). Postnatal rodent spinal cords may be 93 
isolated and sustained in artificial cerebrospinal fluid in vitro, and rhythmic locomotor-related 94 
activity can be evoked in the hindlimb motor circuitry by application of agonists of glutamate and 95 
monoamine receptors, or by electrical or optogenetic stimulation (Kudo and Yamada 1987; Smith 96 
and Feldman 1987; Kiehn and Kjaerulff 1996; Whelan et al. 2000; Hägglund et al. 2013). Isolated 97 
networks generate rhythmic activity in hindlimb muscles, if present, or in transected ventral roots 98 
containing the motoneurons that innervate them (Kudo and Yamada 1987; Smith and Feldman 1987; 99 
Hayes et al. 2009). In preparations in which the ventral roots are transected, field-potential 100 
(electroneurogram) recordings reveal a pattern of rhythmic bursting in the lumbar ventral roots 101 
corresponding to activity observed during treadmill locomotion in adult animals (Cowley and 102 
Schmidt 1994; Kiehn and Kjaerulff 1996; Whelan et al. 2000). Bursting in lumbar ventral roots L1-4 is 103 
in phase with hindlimb flexors and is out of phase with bursting in roots L5 and L6, which corresponds 104 
to bursting in extensors. 105 
The basic output of the locomotor CPG is determined by the intrinsic electrical properties of the 106 
neurons that constitute the network and the synaptic connections between them (Grillner 2006). 107 
Neuromodulators adjust both, enabling a circumscribed population of neurons to produce diverse 108 
outputs and modes of adaptive behavior (Katz and Frost 1996; Katz 1999; Dickinson 2006; Harris-109 
Warrick 2011; Miles and Sillar 2011). Alterations to motor-network output allow animals to adjust 110 
their behavior according to developmental stage, physiological state, and to meet the challenges of 111 
different environmental conditions (Grillner, 2006). For instance, changes in flexor-extensor 112 
coordination within locomotor networks underlie transitions from one gait to another, and gait 113 
changes allow animals to efficiently vary the speed of their locomotion (Orlovsky et al. 1999; 114 
Bellardita and Kiehn 2015). Multifarious neuromodulatory influences acting in concert give rise to a 115 
vast repertoire of network and behavioral outputs and are thus a source of considerable behavioral 116 
flexibility (Harris-Warrick, 2011; Miles and Sillar, 2011). The iterative nature of fictive locomotor 117 
activity facilitates comparison of control and treatment conditions, and isolated spinal networks 118 
have been used to study the effects of diverse neuromodulators at the network level, by application 119 
of pharmacological and genetic tools. Although neuromodulation in locomotor networks has 120 
received considerable attention, evidence that neuron-glia interactions play a role has only recently 121 
emerged (Witts et al. 2012; Acton and Miles 2015). 122 
Gliotransmission 123 
Glia are a class of cell within the central and peripheral nervous systems consisting of macroglia – 124 
which include astrocytes, oligodendrocytes and Schwann cells – and microglia (Verkhratsky and Butt 125 
2013). Astrocytes, like the other glial cell-types, are traditionally considered to have a merely 126 
passive, supportive function within neural networks, with well-established roles in ion homeostasis 127 
and the synthesis and clearance of neurotransmitters (Verkhratsky and Butt 2013). However, 128 
substantial evidence now indicates that astrocytes are active participants at tripartite synapses, 129 
dynamically regulating neuronal excitability and synaptic strength by the release of gliotransmitters 130 
(Araque et al. 1999, 2014; Haydon and Nedergaard 2015; Bazargani and Attwell 2016). In its original 131 
formulation, the tripartite-synapse model entails (1) the binding of a neurotransmitter released 132 
during synaptic activity to an astrocytic Gαq-linked G-protein coupled receptor (GPCR); (2) the 133 
production of inositol trisphosphate (IP3) and activation of IP3 receptors, triggering release of Ca
2+ 134 
from stores within the astrocyte; (3) Ca2+-dependent release of a gliotransmitter such as glutamate 135 
(Parpura et al. 1994; Pasti et al. 1997; Bezzi et al. 1998; Oh et al. 2012; Han et al. 2013), adenosine 136 
triphosphate (ATP) (Newman 2001; Pryazhnikov and Khiroug 2008) or D-serine (Mothet et al. 2005; 137 
Henneberger et al. 2010) by vesicular exocytosis or via ion channels; and (4) the activation of 138 
metabotropic or ionotropic receptors on either the pre- (Jourdain et al. 2007; Carlsen and Perrier 139 
2014) or postsynaptic neuron (Parri, 2001; Angulo 2004; Fellin et al. 2004) (Fig. 1) of the same 140 
(Navarrete and Araque 2010; Martin et al. 2015) or a different (Zhang et al. 2003; Pascual et al. 141 
2005; Serrano et al. 2006) synapse. Although signaling in this manner has been denoted 142 
“gliotransmission”, this is arguably a misnomer: modulation of neuronal activity by substances 143 
derived from astrocytes occurs on a variable timescale, but owing to its dependency on 144 
metabotropic receptors, is necessarily slower than acute transmission mediated by ionotropic 145 
receptors (Agulhon et al. 2012; Araque et al. 2014). “Gliomodulation” has therefore been proposed 146 
as a more appropriate term to distinguish bidirectional signaling between neurons and glia (Agulhon 147 
et al. 2012), but is not widely used (“gliotransmission” will be used in this review). 148 
The steps in the pathway described above have been deduced largely from Ca2+ imaging of 149 
astrocytes and electrophysiological recordings from neurons, and are supported by numerous 150 
studies (Haydon and Nedergaard 2015). However, the extent to which gliotransmission is important 151 
for the operation of neural networks and in the production of behavior in healthy animals remains 152 
controversial (Hamilton and Attwell 2010; Agulhon et al. 2012; Nedergaard and Verkhratsky 2012; 153 
Sloan and Barres 2014; Bazargani and Attwell 2016). The coding of information by astrocytes in the 154 
form of Ca2+ fluctuations, which vary in kinetics and subcellular localization, is poorly understood, 155 
and the physiological relevance of experimental manipulations used to investigate Ca2+ signaling is 156 
disputed (Nedergaard and Verkhratsky 2012; Rusakov 2015). Crucially, evidence is lacking that 157 
gliotransmission dependent on astrocytic Gαq-linked GPCRs and Ca
2+ signaling is important in the 158 
generation of behavior. 159 
Gliotransmission and behavior 160 
Reports have indicated astrocytic involvement in diverse behaviors (reviewed in Oliveira et al. 2015); 161 
these include sleep (Halassa et al. 2009; Foley et al. 2017; however see Fujita et al. 2014), pain 162 
aversion (Foley et al. 2011), recognition memory (Halassa et al. 2009; Florian et al. 2011) motor 163 
coordination (Watase et al. 1998), whisker-dependent perception (Han et al. 2014), olfactory 164 
responses (Martin et al. 2012), and anxiety-like and depressive behavior (Banasr and Duman 2008; 165 
John et al. 2012; Cao et al. 2013). However, despite extensive evidence for bidirectional 166 
communication between neurons and astrocytes in in vitro preparations, evidence that 167 
gliotransmission is important for the production or modulation of behavior is sparse (for further 168 
discussion, see Hamilton and Attwell 2010; Agulhon et al. 2012; Nedergaard and Verkhratsky 2012; 169 
Sloan and Barres 2014; Bazargani and Attwell 2016). Uncertainty about the contribution of 170 
gliotransmission to the generation of behaviors stems from a lack of acute and selective techniques 171 
for the manipulation of astrocytes in vivo and uncertainty about the physiological relevance of 172 
techniques that have been applied to the study of gliotransmission to date (reviewed in Nedergaard 173 
and Verkhratsky 2012 and Bazargani and Attwell 2016). Importantly, mice lacking IP3R2, the IP3 174 
receptor isoform that is preferentially expressed in astrocytes, (IP3R2KO mice) have been tested for a 175 
range of behaviors, including locomotion, learning, memory and anxiety, but do not differ from wild 176 
type littermates on most measures (Agulhon et al. 2013; Petravicz et al. 2014); however, the 177 
possibility that the importance of IP3R signaling is masked in these studies by compensatory 178 
mechanisms during development cannot be excluded. Until further behavioral evidence for 179 
gliotransmission in healthy animals is provided, it will remain controversial.  180 
Given the limitations of the techniques currently available for studying gliotransmission in behaving 181 
animals, in vitro and in vivo rhythmically active brainstem and in vitro spinal cord preparations may 182 
provide insight into the role of bidirectional neuron-glia signaling in behavior. Studies of brainstem 183 
networks for respiration and mastication have provided cogent evidence for behaviorally relevant 184 
gliotransmission. In the brainstem, astrocytic Ca2+ elevations are evoked by reductions in both pH 185 
(Gourine et al. 2010; Kasymov et al. 2013) and the partial pressure of oxygen (Angelova et al. 2015), 186 
in both cases causing release of ATP, which stimulates breathing. In intact rats, optogenetic 187 
stimulation of astrocytes also triggers release of ATP to stimulate breathing (Gourine et al. 2010), 188 
whereas expression of tetanus toxin in astrocytes to inhibit vesicular release prevents increases in 189 
respiration normally observed in response to reduced oxygen availability (Angelova et al. 2015). The 190 
release of modulators from astrocytes described by these studies departs from the tripartite synapse 191 
model, however, as it is stimulated by astrocytic chemoception, rather than detection of a 192 
neurotransmitter. Glia are also proposed to modulate neuronal responses to ATP within the 193 
preBötzinger complex (preBötC), an area of the medulla critical for production of the respiratory 194 
rhythm, by releasing glutamate in a Ca2+ dependent manner (Huxtable et al. 2010). A further 195 
example of neuron-glia crosstalk in a rhythmic network is provided by the brainstem circuity for 196 
mastication, where sensory input is proposed to activate astrocytic N-methyl-D-aspartate (NMDA) 197 
receptors, eliciting release of the Ca2+-binding protein S100β, with the resulting decrease in 198 
extracellular Ca2+ concentration conferring rhythmic bursting properties on neighboring neurons 199 
(Morquette et al., 2015). Evidence from networks that generate rhythmic, stereotyped motor 200 
behaviors - including evidence from the locomotor CPG, described below – may therefore help to 201 
illuminate the extent to which astrocytes participate in information processing within the nervous 202 
system of intact animals. 203 
Evidence for gliotransmission in the spinal cord 204 
Glial Ca2+ signaling 205 
Although a substantial literature is dedicated to the role of astrocytic information processing in in 206 
vitro brain preparations, research into gliotransmission in the spinal cord is in its infancy. 207 
Information about the dynamics of Ca2+ signaling in astrocytes has been provided for the most part 208 
by studies in the cortex, hippocampus and cerebellum. Ca2+ signaling in astrocytes has been 209 
extensively studied by imaging cells expressing a genetically encoded Ca2+ indicator or loaded with 210 
Ca2+-sensitive dyes by means of a patch pipette. Astrocytes are acutely sensitive to neuronal activity, 211 
to the extent that they can respond to basal synaptic activity stimulated by a single action potential 212 
(Panatier et al. 2011). They display intracellular Ca2+ elevations in response to neuronal activity in 213 
both neonatal and adult rodents in vitro and in vivo (Araque et al. 2014; Bazargani and Attwell 2016; 214 
Rusakov 2015; Shigetomi et al. 2016). Ca2+ signaling is observed in awake mice in response to 215 
sensory stimulation in the brain and dorsal horn of the spinal cord (Srinivasan et al. 2015; Sekiguchi 216 
et al. 2016), and during locomotion in the cortex (Dombeck et al. 2007).Given these observations, 217 
astrocytes within the ventral horn of the spinal cord may be expected to display rhythmic oscillations 218 
corresponding to those of neuronal components of the locomotor CPG during network activity. 219 
Although imaging of ventral horn astrocytes in behaving animals may be challenging because of the 220 
difficulty of accessing tissue, it is possible to detect Ca2+ signaling in astrocytes in in vitro 221 
preparations during network activity.  Preliminary studies have reported rhythmic Ca2+ fluctuations 222 
in putative astrocytes during pharmacologically induced locomotor-related activity in in vitro 223 
hemicord preparations (Chub et al. 2012). Furthermore, Ca2+ fluctuations are selectively blocked 224 
during inhibition of metabotropic glutamate receptor 1 (mGluR1) during ventral root stimulation in 225 
disinhibited preparations, implying a role for that receptor in neuron-glia signaling in the spinal cord, 226 
as reported in the brain (Chub and O’Donovan 2011). Consistent with these results, a subset of 227 
astrocytes in the preBötC displays rhythmic Ca2+ activity immediately preceding rhythmic respiratory-228 
related neuronal bursts (Okada et al. 2012; Oku et al. 2015). Interestingly, preBötC astrocytes also 229 
display low-frequency synchronized Ca2+ transients during network activity, indicating a complex 230 
relationship between activity in neurons and astrocytes in this network. This finding suggests that 231 
astrocytes in locomotor networks may also display patterns of Ca2+ signaling that do not directly 232 
correspond to rhythmic locomotor-related activity in neurons.  Apart from preliminary evidence 233 
from the Ca2+-imaging studies cited above, indirect evidence also supports neuron-to-astrocyte 234 
signaling in the spinal cord; this is discussed below. 235 
 236 
Stimulation of spinal cord astrocytes 237 
A range of techniques is available for the experimental induction of astrocytic Ca2+ elevations (for 238 
further information see: Araque et al. 1999; Nedergaard and Verkhratsky 2012 and Bazargani and 239 
Attwell 2016), including ultraviolet (UV) photolysis of caged Ca2+ or IP3 introduced via a patch 240 
pipette (Hua et al. 2004; Wang et al. 2013; Martin et al. 2015), depolarisation of the astrocyte under 241 
whole-cell patch-clamp conditions (Kang et al. 1998; Jourdain et al. 2007), mechanical stimulation 242 
(Hua et al. 2004; Lee et al. 2015), activation of endogenous or transgenically expressed GPCRs, 243 
including DREADDs (designer receptors exclusively activated by designer drugs)  (Rae and Irving 244 
2004; Shigetomi et al. 2008; Agulhon et al. 2010, 2013; Chen et al. 2016), and activation of 245 
transgenically expressed channelrhodopsins (Gourine et al. 2010; Li et al. 2012; Beppu et al. 2014). 246 
Recent studies of gliotransmission in the spinal cord have exploited protease-activated receptor-1 247 
(PAR1) to trigger or enhance astrocytic Ca2+ signaling (Carlsen and Perrier 2014; Acton and Miles 248 
2015). PAR1 is an endogenous GPCR associated with Gαq proteins, and selective activation by a 249 
synthetic ligand results in Ca2+ elevations in astrocytes (Lee et al. 2007; Shigetomi et al. 2008; Lalo et 250 
al. 2014). In the spinal cord (Acton and Miles 2015), as in the brain (Weinstein et al. 1995; Junge et 251 
al. 2004), PAR-1 is expressed by cells that also express glial fibrillary acidic protein (GFAP), an 252 
intermediate filament protein used widely as an astrocyte marker (Wang and Bordey 2008); by 253 
contrast, neurons do not appear to express the receptor in the ventral horn (Acton and Miles 2015). 254 
Cells expressing PAR1 in the spinal cord are therefore proposed to be astrocytes. However, the 255 
possibility that a subset of neural precursor cells of the astrocyte lineage also expresses PAR1 has 256 
not been excluded; gliogenesis continues during postnatal stages at which network-level and single-257 
cell recordings are typically made (Tien et al. 2012), and it has been proposed that some neural 258 
precursor cells express GFAP in the spinal cord during postnatal development (Chvátal et al. 1995). 259 
In addition, the adult spinal cord contains GFAP+ multipotent neural stem cells that are quiescent 260 
within the intact spinal cord (Fiorelli et al. 2013). Such populations of non-astrocytic GFAP+ cells 261 
must therefore be taken into account when interpreting studies using GFAP as a marker of 262 
astrocytes in the spinal cord. Whether PAR1 activation results in Ca2+ signaling exclusively in 263 
terminally differentiated astrocytes remains to be confirmed, as does the proportion of astrocytes 264 
that expresses PAR1. Nevertheless, PAR1 activation offers several advantages as a means of 265 
stimulating astrocytes in the spinal cord: activation of PAR1 does not affect activity in locomotor 266 
networks following pharmacological ablation of astrocytes, indicating that it does not directly 267 
modulate the activity of other cell types (Acton and Miles 2015) - similarly, it does not alter the 268 
excitability of neurons in the brain (Lee et al. 2007; Shigetomi et al. 2008; Lalo et al. 2014); it is 269 
expressed from early postnatal stages in cells across the ventral horn, allowing those cells to be 270 
stimulated concurrently during activity of the locomotor CPG by bath-application of a selective PAR1 271 
agonist;  finally, because it is an endogenous receptor, experimental PAR1 activation may result in 272 
Ca2+ elevations with spatiotemporal properties close to those generated by GPCR activation during 273 
neural activity in vivo, which may not be the case for transgenically expressed receptors. 274 
During pharmacologically induced network activity in in vitro spinal cord preparations from postnatal 275 
mice, stimulation of glia by PAR1 activation results in a transient reduction in the frequency but not 276 
the amplitude of rhythmic bursting (Fig 2., A-D) (Acton and Miles 2015). This effect is blocked by 277 
theophylline, a non-selective adenosine-receptor antagonist, and cyclopentyl dipropylxanthine 278 
(DPCPX), a selective antagonist of A1-adenosine receptors, indicating that it is mediated by 279 
adenosine. Extracellular adenosine is largely formed when ATP is released from cells and then 280 
hydrolyzed by ectonucleotidases in the extracellular space, although adenosine may also be secreted 281 
from cells directly (Cunha 2001; Klyuch et al. 2012; Wall and Dale 2013). Given that the activity of 282 
spinal neurons is unaltered when glia are stimulated in the presence of an ectonucleotidase 283 
inhibitor, spinal glia appear to release ATP rather than adenosine itself (Carlsen and Perrier 2014; 284 
Acton and Miles 2015).  285 
It is interesting that inhibition of A1 receptors during fictive locomotion is sufficient to block the 286 
effects of PAR1 stimulation, suggesting that ATP-adenosine is the only gliotransmitter produced in 287 
these experiments (Acton and Miles 2015). By contrast, stimulation of astrocytes in the dorsal horn 288 
has been shown to elicit release of glutamate (Bardoni et al. 2010; Nie et al. 2010), and astrocytes in 289 
the brain release substances including glutamate, D-serine and GABA (Araque et al. 1999, 2014), all 290 
of which modulate spinal motor networks (Wang and Dun 1990; Bertrand and Cazalets 1999; 291 
Iwagaki and Miles 2011; Miles and Sillar 2011; Acton and Miles 2017). Astrocytes in the ventral horn 292 
may not, therefore, match neurons in the diversity of neuromodulatory substances they secrete. 293 
However, some techniques fail to elicit gliotransmitter release in preparations where others are 294 
effective (Shigetomi et al. 2008; Wang et al. 2013). Activation of either PAR1 or the purinergic 295 
receptor P2Y1, both endogenous astrocytic Gαq-linked GPCRs, elicits Ca
2+ elevations of similar 296 
amplitude in the somas of astrocytes in the CA1 region of the hippocampus, but only PAR1 activation 297 
stimulates gliotransmitter release. The cause of this discrepancy is unknown, but could, for instance, 298 
be related to differences in the subcellular localization of the receptors in relation to Ca2+ stores and 299 
sites of gliotransmitter release (Bazargani and Attwell 2016). For this reason, it is desirable that 300 
several techniques for stimulating astrocytes be compared in future studies. In addition, the 301 
experiments described above do not fully consider state-dependent differences in gliotransmission. 302 
It is conceivable that the influence of astrocyte-derived modulators varies according to the 303 
fluctuating neuromodulatory milieu of the spinal cord (Gerin et al. 1995; Gerin and Privat 1998; 304 
Acevedo et al., 2016; Bazargani and Attwell 2016). State-dependent modulation of networks by 305 
astrocytes may involve changes in the competence of astroyctes to detect neuronal activity or 306 
release modulators, or changes in neuronal sensisitivity. The possibility that adenosinergic 307 
modulation is dependent on the actions of dopamine is discussed below. 308 
In agreement with adenosine release during network activity, PAR1 activation elicits the release of 309 
ATP-adenosine from ventral horn glia in slice preparations from postnatal mice, reducing the 310 
amplitude of evoked excitatory post-synaptic currents (EPSCs) recorded from interneurons via a 311 
presynaptic mechanism mediated by A1 receptors (Carlsen and Perrier 2014). Also, consistent with 312 
findings from rhythmically active preparations, this depends on extracellular ectonucleotidase 313 
activity, indicating that adenosine but not ATP modulates ventral horn interneurons. However, 314 
despite apparent agreement, it remains unclear whether adenosine acts via a common mechanism 315 
in spinal cord slices and rhythmically active isolated spinal cord preparations (see below). 316 
Suppression of gliotransmission in the spinal cord 317 
Endogenous release of substances from astrocytes can be suppressed by inhibition of astrocytic Ca2+ 318 
signaling by various strategies, including dialysis of astrocytic syncytia by Ca2+ buffers and inhibition 319 
of IP3R signaling (for further information, see: Hamilton and Attwell 2010; Nedergaard and 320 
Verkhratsky 2012; Bazargani and Attwell 2016). In addtion, secretion of gliotransmitters can be 321 
supressed by inhibition of G-protein signal transduction (Di Castro et al. 2011), disruption of vesicle 322 
release mediated by N-ethylmaleimide–sensitive factor attachment protein receptor (SNARE) 323 
proteins, (Araque et al. 2000; Jourdain et al. 2007; Gourine et al. 2010; Lalo et al. 2014; Sultan et al. 324 
2015) or by conditional expression of toxins (Angelova et al. 2015) or a dn-SNARE, a dominant-325 
negative cytosolic domain of vesicle-associated membrane protein 2 (VAMP2; aka synaptobrevin 2) 326 
(Pascual et al. 2005; Fellin et al. 2009; Fujita et al. 2014; Lalo et al. 2014; Sultan et al. 2015).  327 
Suppression of astrocytic Ca2+ signaling has not been achieved during locomotor-related network 328 
activity in spinal cord preparations, and techniques for selective and acute inhibition of astrocytic 329 
Ca2+ signaling are currently unavailable. In acute spinal cord slices from mice, loading astrocytes with 330 
a Ca2+ chelator enhances the amplitude of EPSCs in neighboring neurons (Carlsen and Perrier, 2014). 331 
Although this is proposed to reflect a reduction in Ca2+-dependent release of ATP-adenosine from 332 
glia, this has not been tested directly. It has, however, been shown that adenosinergic modulation of 333 
network activity is prevented in murine preparations in which astrocytes have been treated with 334 
gliotoxins, which comprehensively disrupt astrocytic function (Clarke 1991; Fonnum et al. 1997; 335 
Zhang et al. 2003; Huxtable et al. 2010; Witts et al. 2012; Li et al. 2013; Wall and Dale 2013). 336 
Network activity persists following application of the gliotoxins methionine sulfoximine or 337 
fluoroacetate if glutamine, the astrocyte-derived precursor of glutamate and GABA, is supplemented 338 
to support rhythmic activity (Witts et al. 2012). Methionine sulfoximine irreversibly inhibits the 339 
astrocytic enzyme glutamine synthetase and causes glycogen accumulation and cell damage in 340 
astrocytes but not other glial cells (Ronzio et al. 1969; Phelps 1975; Aschner and Kimelberg 1996; De 341 
Vellis 2002). Fluoroacetate, a precursor of the glial aconitase inhibitor fluorocitrate (Fonnum et al. 342 
1997), is proposed to disrupt astrocyte metabolism by reversible inhibition of the Krebs cylcle, 343 
resulting in decreased production of ATP (Paulsen et al. 1987; Keyser and Pellmar 1994; Aschner and 344 
Kimelberg 1996). Following astrocytic ablation by either substance, blockade of adenosine receptors 345 
by DPCPX or theophylline has no effect on network output, revealing that endogenous adenosine no 346 
longer modulates network activity, although preparations remain sensitive to exogenous adenosine 347 
(Fig 2., E-F) (Witts et al. 2012). It should be noted that extensive disruption of astrocytic metabolism 348 
is an imprecise technique for suppressing gliotransmission, and off-target effects of gliotransmitters 349 
have been reported, including changes in extracellular potassium levels (Largo et al. 1997) and 350 
glycogen deposition in cranial motoneurons (Young et al. 2005). However, spinal cord preparations 351 
remain sensitive to adenosine following gliotoxin treatment, consistent with disruption of 352 
endogenous release of adenosine from astrocytes (Witts et al. 2012). Thus, astrocytes are proposed 353 
as the source of modulatory adenosine in the mammalian spinal cord during locomotor-related 354 
activity, despite reported release of adenosine from neurons and microglia in other systems (Wall 355 
and Dale 2013; Jackson et al. 2017). 356 
Adenosine is also released in the spinal cord during hypoxia and hypocapnia, and depresses reflex 357 
potentials recorded from the ventral roots (Lloyd et al. 1988; Otsuguro et al. 2006, 2009, 2011). 358 
Release of adenosine during hypoxia, although not hypocapnia, is inhibited by fluoroacetate, 359 
implying an astrocytic source (Takahashi et al. 2010). However, in this context it is not clear whether 360 
adenosine acts on spinal cord neurons or on peripheral afferents. In addition, it should be noted that 361 
in primary cultures of brain cells, oxidative stress was found to elicit release of adenosine from 362 
microglia and not from astrocytes or neurons (Jackson et al. 2017). 363 
Together, these experiments demonstrate that activation of Gαq-coupled GPCRs expressed by 364 
putative astrocytes in the spinal cord results in the production of adenosine, which in turn 365 
modulates neuronal activity via A1 adenosine receptors. Production of modulatory adenosine 366 
following release of ATP from astrocytes appears to be widespread throughout the CNS, having also 367 
been reported in brain preparations (Pascual et al. 2005; Serrano et al. 2006; Panatier et al. 2011). 368 
Indirect evidence for neuron-to-glia signaling in motor networks 369 
The tripartite synapse model implies detection of neuronal activity by astrocytes, which respond 370 
with elevations in cytosolic Ca2+.  Indirect support for neuron-to-astrocyte signaling during locomotor 371 
network activity is provided by the observation that modulation of the frequency of locomotor-372 
related activity by endogenous adenosine scales with network activity (Acton and Miles 2015). This 373 
presumably represents activity-dependent release of ATP-adenosine by astrocytes, and implies that 374 
ventral horn astrocytes detect neuronal activity; for instance, by detection of neurotransmitter 375 
release, as predicted by the tripartite synapse model. Astrocytes are therefore proposed to mediate 376 
a negative feedback loop, whereby activity-dependent release of adenosine depresses and perhaps 377 
stabilizes network output, resulting in smooth, controlled movement (Acton and Miles 2015). 378 
However, further Ca2+ imaging is needed to confirm spinal astrocytic responsiveness to neuronal 379 
activity, as has been demonstrated in the brain (Araque et al. 2014; Bazargani and Attwell 2016; see 380 
above).  381 
Interestingly, it has been observed that astrocytes express receptors for the neurotransmitters 382 
released specifically by the neurons they make contact with, implying that astrocytic receptors 383 
function to detect synaptic transmission (Verkhratsky and Butt 2013). Thus, spinal cord astrocytes 384 
are unusual in expressing receptors for glycine, the dominant inhibitory neurotransmitter in the 385 
spinal cord (Pastor et al. 1995; Bowery and Smart 2006). Both GlyRs and GABAA receptors expressed 386 
by spinal cord astrocytes carry a Cl- current, as they do in neurons (Pastor et al. 1995). Spinal cord 387 
astrocytes also express NMDA receptors and are sensitive to glutamate (Ziak et al. 1998); however, 388 
the physiological importance of these currents remains unknown. 389 
Adenosinergic modulation of spinal motor circuitry 390 
The purines ATP and its derivative adenosine are involved in a myriad of biological processes, most 391 
notably energy transfer. In the nervous system, they also function as neuromodulators, and are 392 
involved in diverse processes in health and disease, including sleep homeostasis, memory, and the 393 
regulation of mood (Cunha 2001; Fredholm et al. 2005; Burnstock 2007). Experiments indicating 394 
release of modulatory adenosine from astrocytes in the ventral horn are complemented by studies 395 
into the functions and mechanisms of purinergic signaling during motor activity. However, some 396 
data point to unresolved complexity. 397 
There are four adenosine receptor subtypes, designated A1, A2A, A2B and A3, which differ in affinity 398 
for adenosine, structure, cellular distribution, and G-protein coupling (Cunha 2001; Dunwiddie and 399 
Masino 2001). A1 and A2A receptors have the highest affinity for adenosine and are the best 400 
characterized (Cunha 2001). Both receptors are expressed throughout the spinal cord (Reppert et al. 401 
1991; Deuchars et al. 2001; Paterniti et al. 2011). A1 receptors are tightly coupled to the Gαi pathway, 402 
which mediates inhibition of adenylyl cyclase and reduced production of cAMP (Cunha 2001). 403 
However, A1 receptors are also coupled to other G proteins and act via adenylyl cyclase-independent 404 
pathways to inhibit spontaneous and evoked neurotransmitter release (Cunha 2001). A1 receptors 405 
typically mediate presynaptic inhibition via the adenylyl cyclase-independent inhibition of N-type 406 
Ca2+ channels (Ribeiro 1995; Cunha 2001). A2A receptors are primarily coupled to Gαs, but also to Gαi 407 
and Gα12, and have diverse effects mediated by PKA, PKC, N-type and P-type calcium channels 408 
(Cunha 2001). In many systems, the inhibitory actions of A1 receptors are countered by the 409 
facilitatory actions of A2A receptors in a concentration-dependent manner (Cunha 2001).  410 
The role of adenosine signaling in the modulation of mammalian locomotor behavior has been 411 
addressed by injection of intact animals with receptor antagonists, such as caffeine, which typically 412 
have an excitatory effect. This effect has been proposed to be mediated by either A1 (Snyder et al. 413 
1981; Goldberg et al. 1985), A2A (Svenningsson et al. 1995, 1997; Ledent et al. 1997; El Yacoubi et al. 414 
2000; Lindskog et al. 2002) or both A1 and A2A receptors (Karcz-Kubicha et al. 2003; Antoniou et al. 415 
2005; Kuzmin et al. 2006), perhaps indicating a role for both receptor subtypes. However, 416 
interpretation of studies in which antagonists are chronically applied is complicated by the reported 417 
acquisition of receptor tolerance, to which A1 receptors are particularly susceptible (Karcz-Kubicha et 418 
al. 2003). It is also difficult to draw conclusions about the locus or loci of adenosinergic modulation:  419 
it is likely that adenosine regulates locomotion in multiple regions of the nervous system involved in 420 
motor control, including the basal ganglia (Popoli et al. 1996) and ventral spinal cord (Witts et al. 421 
2012; Acevedo et al. 2016), and the effects of adenosine blockade in one network may mask its 422 
effects in another. 423 
Experiments in which in vitro rodent spinal cord preparations were exposed to adenosine-receptor 424 
agonists and antagonists have addressed the role of adenosine specifically within spinal locomotor 425 
networks. During locomotor-related activity induced by bath application of 5-HT, NMDA and DA in 426 
neonatal mouse preparations, blockade of A1 receptors results in increased burst frequency (Witts et 427 
al. 2012; Acevedo et al. 2016), with no effect on amplitude, whereas blockade of A2A receptors has 428 
no effect (Witts, Panetta and Miles, 2012; Acevedo et al., 2016). Conversely, bath application of 429 
adenosine or an A1-selective agonist, but not an A2A agonist, results in reduced burst frequency in a 430 
dose-dependent manner, again with no effect on amplitude (Witts, Panetta and Miles, 2012; 431 
Acevedo et al., 2016). The frequency effects are associated with changes in burst and cycle duration, 432 
implying no change in duty cycle (Acevedo et al., 2016). Bath application of ATP has a similar effect 433 
to adenosine in reducing burst frequency (Witts, Panetta and Miles, 2012); however, both blockade 434 
of adenosine receptors and application of ATP have no effect in the presence of an ectonucleotidase 435 
inhibitor. This indicates that endogenous adenosine is derived from ATP released into the 436 
extracellular space, that ATP itself does not modulate locomotor-related activity, and that both 437 
endogenous and exogenous ATP are efficiently degraded to adenosine within the murine spinal cord 438 
(Witts, Panetta and Miles, 2012). The effects of bath-applied and endogenous adenosine therefore 439 
closely resemble those of ATP-adenosine released upon glial stimulation during network activity 440 
(Acton and Miles 2015). 441 
Modulation of the frequency but not the amplitude of locomotor-related activity by adenosine 442 
suggests that it acts on the premotor circuitry rather than on motoneurons (Miles and Sillar, 2011). 443 
Consistent with this hypothesis, neither exogenous adenosine nor adenosine released following 444 
PAR1 activation modulates disinhibited activity mediated by motoneurons and excitatory 445 
components of the locomotor circuitry alone (Witts, Panetta and Miles, 2012), implying that 446 
adenosine exerts its depressive effects via inhibitory interneurons, which may include the V1 447 
population, for example (Fig. 3a). Ablation or inhibition of V1 interneurons reduces the frequency of 448 
locomotor-related activity, similar to the effects of adenosine acting at inhibitory A1 receptors 449 
(Gosgnach et al. 2006). However, disinhibited activity, which is generated by spinal cord 450 
preparations following application of GABAA- and glycine-receptor antagonists, is produced by a 451 
modified network, and caution must therefore be applied when comparing the effects of adenosine 452 
under disinhibited conditions and during fictive locomotion. 453 
The effects of bath-applied adenosine on neurons in acute slices from postnatal mice have also been 454 
assessed. Adenosine modulates a broad population of ventral horn interneurons, representing both 455 
excitatory and inhibitory populations. In these cells, adenosine acts via presynaptic A1 receptors to 456 
reduce the frequency of miniature postsynaptic currents (mPSCs) (Witts et al. 2015) and the 457 
amplitude of evoked excitatory post-synaptic currents (eEPSCs) in a paired simulation protocol 458 
(Carlsen and Perrier 2014). Thus, adenosine acting at A1 receptors inhibits synaptic transmission 459 
onto interneurons. In addition, A1 receptor activation induces a hyperpolarizing current in ventral 460 
horn interneurons (Witts et al. 2015). In contrast, adenosine induces a depolarizing current in 461 
motoneurons by an unknown mechanism that is sensitive to TTX, although adenosine does not 462 
appear to directly modulate synaptic inputs onto motoneurons (Witts et al. 2015). Interestingly, A1-463 
receptor blockade alone has no effect in recordings from neurons within spinal cord slices. It is 464 
possible that there is insufficient adenosine present in slices for the tonic activation of these 465 
receptors, or that adenosine at the concentrations at which it exists in the spinal cord requires 466 
concurrent activation of D1-like receptors to exert modulatory effects (Acevedo et al. 2016; see 467 
below).  468 
Data suggest differences in purinergic modulation between rats and mice. In isolated rat spinal cord 469 
preparations, bath-applied adenosine enhances burst amplitude during pharmacologically induced 470 
locomotor-related activity and depresses the frequency of disinhibited bursting in an A1-dependent 471 
manner (Taccola et al. 2012), effects not observed in mouse preparations (Witts et al. 2012; Acevedo 472 
et al. 2016). In addition, the duration of bouts of locomotor-related activity induced by dorsal-root 473 
stimulation in rat spinal cord preparations is reduced by exogenous adenosine (Taccola et al., 2012). 474 
A1 blockade alone has no effect on drug-induced or electrically stimulated locomotor-related activity 475 
in rats (Taccola et al. 2012), whereas in mice A1 blockade increases the frequency of fictive 476 
locomotion (Witts et al. 2012; Acevedo et al. 2016). Differences between mice and rats in purinergic 477 
modulation of respiratory networks have been attributed to species-specific ectonucleotidase 478 
expression (Huxtable et al. 2009; Zwicker et al. 2011), which result in the mouse network being more 479 
strongly modulated by adenosine, and the rat network by ATP. Further experiments are required to 480 
assess whether similar species differences account for the reported differences in the sensitivity of 481 
rat and mouse spinal locomotor networks to adenosine. Differential responses to adenosine may 482 
also relate to differing roles of co-activation of D1-like receptors (Acevedo et al. 2016), but the 483 
potential role D1/A1 co-activation remains to be investigated in the rat spinal cord.  484 
Metamodulation of D1-like dopamine receptors by A1 receptors 485 
Recent data suggests that endogenous adenosine exerts its effects on locomotor-related activity via 486 
second-order modulation of dopamine signaling within the mouse spinal cord (Acevedo et al. 2016). 487 
Dopamine is a potent modulator of spinal motor circuitry, acting via diverse mechanisms to regulate 488 
motor behavior (Miles and Sillar 2011; Sharples et al. 2014). All segments of the mammalian spinal 489 
cord receive dopaminergic or L-DOPAergic inputs from descending fibers originating in the brain, 490 
most notably from the A11 region of the hypothalamus (Björklund and Skagerberg 1979; 491 
Commissiong et al. 1979; Hökfelt et al. 1979; Skagerberg and Lindvall 1985; Koblinger et al. 2014), 492 
and dopamine levels increase within the ventral horn during locomotion (Gerin et al. 1995; Gerin 493 
and Privat 1998). 494 
The five dopamine-receptor subtypes fall into two families: the D1-like receptors are the D1 and D5 495 
subtypes and the D2-like receptors are the D2, D3, and D4 subtypes (Neve 2010; Pieper et al. 2011). 496 
Whereas D1-like receptors signal through Gαq to stimulate phospholipase C and Gαs to stimulate 497 
adenylyl cyclase, D2-like receptors signal through Gαi to inhibit adenylyl cyclase (Abdel-Majid et al. 498 
1998; Pieper et al. 2011). Adenylyl cyclase catalyzes the synthesis of the second messenger cyclic 499 
adenosine monophosphate (cAMP), which activates various proteins including protein kinase A 500 
(PKA). PKA regulates a number of proteins including sodium-dependent ion transporters, various ion 501 
channels, cAMP responsive element binding protein 1 (CREB1) and dopamine and cyclic AMP-502 
regulated phosphoprotein of 32 kDa (DARPP-32) (Abdel-Majid et al. 1998; Undieh 2010). 503 
Dopaminergic modulation of locomotor-related activity in spinal networks is mediated by both D1-504 
like and D2-like receptors (Madriaga et al. 2004; Humphreys and Whelan 2012; Sharples et al. 2015).  505 
A1-adenosine receptors are reported to interact with D1-like dopamine receptors in the spinal 506 
locomotor circuitry (Acevedo et al., 2016), as is observed in the basal ganglia (Popoli et al. 1996), 507 
where they co-localize (Ferré et al. 1992). Dopamine stabilizes locomotor-related activity (Jiang et al. 508 
1999; Whelan et al. 2000; Barrière et al. 2004; Madriaga et al. 2004; Humphreys and Whelan 2012; 509 
Sharples et al. 2015) and is co-applied with 5-HT and NMDA to induce locomotor-related activity in 510 
many studies. It is presumed to be absent in isolated lumbar spinal cord preparations unless 511 
exogenously applied, as descending dopaminergic inputs are severed in in vitro preparations, and 512 
dopamine receptor antagonists do not alter locomotor-related activity induced in the absence of a 513 
dopamine receptor agonist (Barrière et al. 2004). When dopamine is absent or when D1-like 514 
receptors are selectively blocked, A1 blockade no longer alters the frequency of locomotor-related 515 
bursting (Acevedo et al. 2016). A1 blockade is similarly ineffective when the Gαs signaling pathway 516 
through which D1-like receptors signal is inhibited at the level of PKA. However, when forskolin is 517 
applied to activate adenylyl cyclase in a receptor-independent manner, the effect of A1 blockade on 518 
the frequency of locomotor-related bursting is restored.  519 
Collectively, data from isolated spinal cord preparations suggest a model in which astrocytes secrete 520 
ATP during locomotor-related activity in an activity-dependent manner. Adenosine produced by 521 
hydrolysis of this ATP acts through A1 receptors to regulate the activity of locomotor networks by 522 
inhibiting ongoing signaling mediated by D1-like receptors and PKA (Fig. 3b). This may occur through 523 
direct inhibition of adenylyl cyclase mediated by the Gαi pathway to which A1 receptors are coupled, 524 
and it is possible that A1 and D1-like receptors form heterodimers (Franco et al. 2000); however, 525 
colocalization of A1 and D1-like receptors has not yet been demonstrated in the spinal cord. 526 
It is unclear how these results relate to experiments in which adenosine was found to modulate 527 
neuronal activity in the absence of dopamine (Lloyd et al. 1988; Otsuguro et al. 2006, 2009, 2011; 528 
Taccola et al. 2012; Carlsen and Perrier 2014; Witts et al. 2015). It is possible that high 529 
concentrations of adenosine, such as those used for bath applications or produced during hypoxia 530 
and hypocapnia, modulate neural activity independently of dopamine, whereas low levels of 531 
endogenous adenosine require co-activation of D1-like receptors by dopamine. Consistent with this, 532 
A1 blockade has not been shown to modulate neuronal activity in the absence of dopamine (Taccola 533 
et al. 2012; Witts et al. 2012; Acevedo et al. 2016), although it does inhibit effects mediated by 534 
exogenous adenosine or adenosine released in response to a stimulus (Lloyd et al. 1988; Otsuguro et 535 
al. 2006, 2009, 2011; Taccola et al. 2012; Witts et al. 2015); presumably, this indicates low basal 536 
levels of adenosine within the spinal cord. Interestingly, all dopamine-dependent and dopamine-537 
independent effects so far described in in vitro spinal cord preparations from healthy animals are 538 
mediated by A1 receptors, despite expression of A2A receptors in the spinal cord. It is conceivable 539 
that A2A receptors may have a functional role only in responses to injury: following spinal cord injury, 540 
A2A receptors are upregulated in the spinal cord, and administration of a selective A2A antagonist 541 
exerts neuroprotective effects, perhaps by reducing excitotoxicity (Paterniti et al. 2011).  Thus, A1 542 
receptors may participate in multiple signaling pathways, depending on agonist concentration. 543 
The proposed antagonistic interaction between A1 and D1-like receptors implies that D1-like 544 
receptors, which are typically excitatory, enhance the frequency of locomotor-related bursting in 545 
neonatal mice. However, this has not been clearly demonstrated. Although D1-like receptors 546 
typically have excitatory effects, they have not been reported to increase the frequency of ongoing 547 
locomotor-related activity in mice (Humphreys and Whelan 2012; Sharples et al. 2015), but may 548 
instead enhance the stability of rhythmic bursting (Sharples et al. 2015). Bath applied dopamine or a 549 
D1-like receptor agonist stimulates locomotor-related activity in neonatal rat preparations (Kiehn 550 
and Kjaerulff 1996; Barrière et al. 2004) but not in neonatal mouse preparations (Jiang et al. 1999; 551 
Whelan et al. 2000; Sharples et al. 2015); however, the selective D1-like receptor agonist SKF 81927 552 
is able to stimulate locomotor activity in spinalized adult mice (Lapointe et al. 2009). Thus, although 553 
D1-like receptors have excitatory effects within the spinal cord, the enhancement of burst frequency 554 
that A1 receptors are proposed to counteract in spinal cords from neonatal mice has not been 555 
detected.  556 
The effects of dopamine on network activity likely reflect multiple effects mediated by both D1-like 557 
and D2-like signaling pathways within diverse cell populations: dopamine has been shown to 558 
modulate synaptic strength and passive electrical properties of motoneurons and interneurons (Carp 559 
and Anderson 1982; Maitra et al. 1993; Seth et al. 1993; Clemens 2004; Han et al. 2007; Barrière et 560 
al. 2008; Han and Whelan 2009; Humphreys and Whelan 2012). The extent of second-order 561 
modulation of D1-like receptors by adenosine is currently unclear: further experiments are required 562 
to reveal whether adenosine acts on all cells expressing D1-like receptors or only on a subset 563 
involved in the regulation of speed.  Nevertheless, the model by which adenosine is proposed to 564 
modulate the effects of D1-like receptor activation during fictive locomotion is consistent with other 565 
examples of metamodulation, which is proposed as an efficient mechanism for refining the effects of 566 
a first-order neuromodulator; this may be important when the first-order modulator  is widespread 567 
and/or is capable of acting promiscuously on various cell typesto exert diverse effects within a 568 
network (Katz 1999). Metamodulation may entail a second-order neuromodulator regulating the 569 
availability (release or uptake) of a first-order neuromodulator or, as in the present example, 570 
modulation of its effect on a target neuron. Other examples of metamodulation in spinal locomotor 571 
networks are provided by Xenopus tadpoles, in which nitric oxide (NO) modulates the release of 572 
noradrenaline (McLean and Sillar 2004) and lampreys, in which NO modulates the activity of 573 
endocannabinoids (Song et al. 2012). 574 
The physiological importance of glial adenosine in spinal locomotor 575 
networks 576 
Adenosinergic neuromodulation is proposed to have a homeostatic role in diverse systems, 577 
preventing metabolic exhaustion and excitotoxicity (Cunha 2001; Fredholm et al. 2005; Wall and 578 
Dale 2008). Activity-dependent production of adenosine has been detected in the mammalian brain 579 
and brainstem, and in the spinal cord of Xenopus tadpoles (Wall and Dale 2008). In some cases, this 580 
may be coupled to the degradation of ATP. ATP is consumed by neurons as a source of energy during 581 
activity, and adenosine produced by its hydrolysis may be released directly via neuronal equilibrative 582 
nucleoside transporters. Subsequent autocrine inhibition of activity via A1 receptors is proposed as a 583 
mechanism to prevent metabolic exhaustion (Cunha 2001; Fredholm et al. 2005). However, this 584 
mechanism does not appear to operate in some systems, including spinal motor networks in 585 
tadpoles and mice, in which the source of adenosine is ATP released into the extracellular space 586 
from either neurons or astrocytes (Pascual et al. 2005; Serrano et al. 2006; Wall and Dale 2008; 587 
Panatier et al. 2011; Witts et al. 2012; Carlsen and Perrier 2014). Nevertheless, it remains possible 588 
that adenosine functions to avoid metabolic exhaustion, even if its source is not ATP expended as 589 
energy. 590 
Xenopus tadpoles provide an example of purinergic signaling during motor behavior in a non-591 
mammalian vertebrate. ATP released within the spinal cord during episodes of swimming excites the 592 
locomotor CPG, extending the duration of swimming bouts (Dale and Gilday 1996; Dale 1998). As 593 
swimming progresses, ATP is hydrolyzed to adenosine, which activates A1 receptors to drive down 594 
network activity (Brown and Dale 2000). This mechanism may exist to prevent metabolic exhaustion 595 
and excitotoxicity (Wall and Dale 2008). The cellular origin of ATP in the tadpole spinal cord is 596 
unclear, and given recent evidence from Drosophila larvae that neuron-glia crosstalk regulates 597 
behavior of non-mammalian species (Ma et al. 2016), glial release of purines should not be ruled 598 
out. The temporal dynamics of adenosine release in the mammalian spinal cord have not been 599 
investigated; it is possible that gradual increase in adenosinergic tone during motor behaviors could 600 
also have a protective function by preventing metabolic exhaustion.  601 
Summary 602 
Recent studies have provided evidence for the release of ATP-adenosine from astrocytes in the 603 
spinal cord, as previously demonstrated elsewhere in the CNS. Adenosine operates by multiple 604 
pathways within spinal motor circuitry. During fictive locomotion, it is proposed to function as a 605 
second-order modulator of D1-like receptors (Acevedo et al. 2016). This mechanism is likely to be 606 
important in refining the influence of dopamine, which has manifold cellular activities during 607 
locomotor behaviors. The consequent reduction in locomotor speed may be important in ensuring 608 
fluency of movement or have a role in averting cellular fatigue (Witts et al. 2012; Acton and Miles 609 
2015; Acevedo et al. 2016). Adenosine also acts by a dopamine-independent pathway or pathways 610 
(Lloyd et al. 1988; Otsuguro et al. 2006, 2009, 2011; Taccola et al. 2012; Witts et al. 2012; Carlsen 611 
and Perrier 2014), which may be activated only by high concentrations of adenosine. It will be 612 
interesting to compare tissue concentrations of adenosine during inactivity, locomotion and 613 
injurious conditions in which adenosine is released, such as hypoxia and hypercapnia. The 614 
agreement between dopamine-dependent effects mediated by A1-adenosine receptors during fictive 615 
locomotion and the effects of adenosine released upon glial stimulation suggests that the latter acts 616 
via D1-like receptors to modulate rhythmic activity, but this remains to be tested directly. 617 
Although evidence exists for glial release of adenosine (Witts et al. 2012; Carlsen and Perrier 2014; 618 
Acton and Miles 2015), detailed Ca2+ imaging of astrocytes is required to confirm a role for Ca2+-619 
dependent neuron-glia signaling in the ventral horn. However, several studies have provided 620 
evidence for crosstalk between neurons and astrocytes in a manner that departs from the 621 
established tripartite-synapse model (Gourine et al. 2010; Gourine and Kasparov 2011; Torres et al. 622 
2012; McDougal et al. 2013; Angelova et al. 2015). Neurotransmitter uptake is as important as 623 
release in shaping patterns of synaptic transmission, and may be regulated in an activity-dependent 624 
manner independently of Ca2+ signaling (Attwell et al. 1993; Perego et al. 2000; Roux and Supplisson 625 
2000; Marcaggi and Attwell 2004; Li et al. 2009; Al Awabdh et al. 2016; Shibasaki et al. 2016). 626 
Although PAR1 activation does not appear to elicit release of glutamate or its co-agonists at NMDA 627 
receptors, glycine and D-serine (Acton and Miles 2015), it has been proposed that co-agonist 628 
concentrations are regulated by astrocytes in an activity-dependent manner during motor behaviors 629 
(Acton and Miles 2017). In addition, activation of astrocytic GPCRs may result in the modulation of 630 
neuronal activity by Ca2+-independent pathways. Selective activation of a Gαq-coupled DREADD 631 
expressed by astrocytes lacking IP3R2 receptors results in diverse behavioral modifications on a 632 
timescale longer than that predicted for Ca2+-dependent responses; these may involve signaling via 633 
Gβγ or protein kinase C (PKC), for instance (Agulhon et al., 2013). These examples suggest that 634 
information processing by astrocytes is underexplored, and may be crucial in the generation of 635 
behaviors by spinal networks, exceeding their established role as cellular housekeepers. 636 
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Figures 1156 
Figure 1. Established model of bidirectional signaling between neurons and glia at the tripartite 1157 
synapse. Neurotransmitters activate astrocytic Gαq-linked G-protein coupled receptors (GPCRS), 1158 
stimulating the production of inositol-3-phosphate (IP3), activation of astrocytic IP3 receptors (IP3R2) 1159 
and release of Ca2+ from internal stores. An increase in intracellular Ca2+ triggers release of 1160 
gliotransmitters including glutamate, ATP and D-serine by a vesicular or channel-mediated 1161 
mechanism, which in turn bind to pre- or postsynaptic GPCRs - or in the case of D-serine, N-methyl-1162 
D-aspartate (NMDA) receptors – to modulate synaptic strength or neuronal excitability. 1163 
Figure 2. Adenosine derived from glial cells acts via A1 receptors to modulate locomotor-related 1164 
activity in a murine spinal cord preparation. A: an in vitro spinal cord preparation in which suction 1165 
electrodes are used to recording compound action potentials from motoneurons in transected 1166 
ventral roots. B: sample raw (top) and rectified/integrated (bottom) ventral root traces showing 1167 
rhythmic locomotor-related bursting evoked by bath-application of 5-hydroxytryptamine (10 µM), 1168 
NMDA N-methyl-D-aspartate (5 µM) and dopamine (50 µM) in control conditions, following 1169 
application of TFLLR (10 µM) to selectively activated glial protease-activated receptor-1 (PAR1), and 1170 
during washout. Ci: locomotor-burst frequency over 3 min during a control period, immediately 1171 
following TFLLR application, and following a 20-min washout period. Individual data points are 1172 
shown in grey and means are represented by black lines.  Cii: time course plot of normalized data 1173 
aggregated into 1-min bins showing a reduction in burst frequency upon application of TFLLR. n = 10 1174 
preparations. Di: locomotor-burst amplitude is unaffected by TFLLR application. Dii: time course plot 1175 
showing no change in burst amplitude upon application of TFLLR.. Ei: sample traces showing the 1176 
effects of the non-selective adenosine receptor antagonist theophylline (20 µM) on locomotor-1177 
related activity. Eii: theophylline increases the frequency of locomotor-related bursting, revealing 1178 
the modulatory role of endogenous adenosine derived from sources within the ventral horn. n = 6. 1179 
Eiii: the selective A1 adenosine receptor antagonist cyclopentyl dipropylxanthine (DPCPX; 50 µM) 1180 
also reveals modulation of locomotor-related activity by endogenous adenosine, and prevents 1181 
further frequency increases in the presence of theophylline, demonstrating that adenosine acts via 1182 
A1 receptors. n = 6. Fi: traces showing the effects of the glial toxin fluoroacetate (FA; 5 mM) when co-1183 
applied with glutamine (1.5 mM) and a lack of modulation by endogenous adenosine following glial 1184 
ablation, as revealed by  application of theophylline (20 µM). Fii: theophylline has no effect on the 1185 
frequency of locomotor activity when applied in the presence of the glial toxins FA and MSO. n = 6. 1186 
*p < 0.05, **p < 0.01. B-D adapted from Acton & Miles (2015). E-F adapted from Witts, Panetta, & 1187 
Miles (2012). 1188 
Figure 3. Schematic illustrating proposed release of ATP-adenosine from astrocytes and inhibition 1189 
of D1-like receptor signaling within locomotor networks. A: Outline of the spinal locomotor CPG as 1190 
a bilateral network comprising flexor and extensor and rhythm- and pattern-generating modules for 1191 
the coordination of muscle activation during locomotion. Molecularly defined populations of 1192 
postmitotic ventral horn neurons (V1, V2a, V2b, V0v, V0d, V3) are represented as blue circles and 1193 
some of their proposed interactions are indicated by arrows, signifying excitation, or bars, signifying 1194 
inhibition. Astrocytes are proposed to modulate the rhythm-generating circuity by exerting an 1195 
inhibitory effect, via secretion of ATP-adenosine, on an inhibitory population that regulates 1196 
locomotor frequency, possibly the V1 population of interneurons (see text). For details of the roles 1197 
of the neuronal populations indicated, see Goulding (2009) and Kiehn (2016). B: ATP is released from 1198 
putative spinal cord astrocytes during network activity in response to an unidentified neuronal 1199 
signal, and upon experimental activation of the Gαq-linked receptor PAR1 by TFLLR, which is 1200 
proposed to mimic the endogenous action of neurotransmitters on astrocytic GPCRs. Extracellular 1201 
ectonucleotidases mediate the hydrolysis of ATP to adenosine, which activates neuronal Gαi-linked 1202 
A1 receptors to inhibit signaling through Gαs-linked D1-like receptors at the level of adenylyl cyclase. 1203 
Reduced cAMP production by adenylyl cyclase results in reduced activation of PKA. PKA acts on 1204 
unidentified targets, perhaps including ion channels and ionotropic receptors, to reduce neuronal 1205 
excitability, resulting in a reduced frequency of locomotor-related activity. Abbreviations: IN, 1206 
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